loading animation for AJAX calls

194 Reports in Pharmaceuticals

ROI in Pharmaceutical R&D: How to Halt the Decline

Published - Jan 2020 | Publisher - BCC Publishing| Code - PHM218A

The global orphan drugs market should reach $315.6 billion by 2024 from $127.5 billion in 2017 at a compound annual growth rate (CAGR) of 13.8% for the forecast period of 2017 to 2024.

Pediatric Medicines: Global Markets

Published - Dec 2019 | Publisher - BCC Publishing| Code - PHM170B

The global pediatric market should grow from $92.6 billion in 2019 to reach $116.6 billion by 2024 at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2024.

Cannabis Market: Products, Technologies and Applications

Published - Dec 2019 | Publisher - BCC Publishing| Code - PHM217A

The global cannabis market should grow from $25.6 billion in 2019 to $77.6 billion by 2024 at a compound annual growth rate (CAGR) of 24.8% for the period of 2019-2024.

Over-the-Counter (OTC) Drugs and Dietary Supplements: Opportuniti...

Published - Nov 2019 | Publisher - BCC Publishing| Code - PHM219A

This report on Over-the-Counter (OTC) drugs and dietary supplement products market highlights primary healthcare and its various parameters such as the drafting of rules and regulations for OTC drugs and dietary supplements, the number of drugs classified, self-care awareness among consumers and the size of distribution networks, OTC drugs and dietary supplements manufacturers. BCC Research analyzed key categories and regions to determine the present and future OTC drugs and dietary supplement products market status and forecasted market growth.

Significant Drug Launches in 2019: A BCC Research Analysis and In...

Published - Oct 2019 | Publisher - BCC Publishing| Code - PHM220A

This report provides information on significant drug launches in 2019. The study provides an overview of each drug, scientific summaries, pharmacodynamics, pharmacokinetics and clinical trial information, disease backgrounds, analysis of the market, competitors and company profiles of manufacturers. The objective of this study is to present a comprehensive analysis of the current market and its future direction.

Communicable Disease Market: A BCC Research Overview

Published - Aug 2019 | Publisher - BCC Publishing| Code - PHM216A

The global market for communicable disease should grow from $57.7 billion in 2019 to $69.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.8% for the period of 2019-2024.

Continuous Manufacturing in Pharmaceuticals: Implications for the...

Published - Aug 2019 | Publisher - BCC Publishing| Code - PHM214A

This report presents a perspective on the adoption of continuous manufacturing technologies by pharmaceuticals, the role of the FDA and implications for the generics sector.

Neurology Market: A BCC Research Overview

Published - Aug 2019 | Publisher - BCC Publishing| Code - PHM215A

The global market for neurology should grow from $33.3 billion in 2019 to $39.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.5% for the period of 2019-2024.

Interleukin-2, a Tale of Two Halves: To Suppress or Augment Suppr...

Published - Jul 2019 | Publisher - BCC Publishing| Code - PHM212A

The report provides a detailed description of autoimmune responses and possible ways that drug development can augment immune responses so as to improve antitumor activity and reduce off target effect.This report will assess the latest developments in the IL-2 research and development and explore the novel strategies companies are adopting to augment immune response and avoid off target effects in a wide range of conditions including, metastatic melanoma (MM), renal cell carcinoma (RCC), urothelial cancers (US) relapse remitting multiple sclerosis (RRMS), Type 1 diabetes (T1D), as a prophylaxis post-transplant and allergic conditions.What's coming: There are more than 200 studies underway evaluating IL-2 based therapies either as a monotherapy or in combination. The key products and companies that we believe are worth watching in this space are summarized.

Markets at a Glance: Pharmaceuticals

Published - Jun 2019 | Publisher - BCC Publishing| Code - PHM213A

The “Market at a Glance Pharmaceuticals” provides an access to all the market share analysis segments of the best-selling and key pharmaceutical reports of BCC Research. This report is a destination for the competitive landscape in the markets that hold a significant stand in the pharmaceuticals sector. Company profiles for all the notable manufacturers in the global pharmaceutical industry are provided as a part of this report.

Nothing Degrading about Saving Lives: E3 Ligands Recruiting New D...

Published - May 2019 | Publisher - BCC Publishing| Code - PHM192A

Posttranslational modifications hit prime time in the pharma industry. There probably isn’t a medium sized biopharmaceutical that does not have an active program ongoing, and certainly all of the big pharma companies are running multiple programs, and collaborations, for what we might have previously termed “undruggable targets”. Many of these are for highly unmet needs in neurodegeneration. The properties of the structure that forms between a target, a degrader and an E3 ligase, are under intense investigation. Minor changes affect how the drugs work - this can explain how promiscuous target-binding payloads can achieve super selectivity when transformed into a degrader. These minor alterations can also render the molecule complex not only ineffective, but sometimes toxic. However, clinical results are beginning to write a compellingly effective story – the long and winding history of research into the ubiquitin proteasome may well have more blockbusters in store for us. And cures in a once overlooked corner of the cell machinery architecture.

Colorectal Cancer Therapeutics: Global Markets

Published - Apr 2019 | Publisher - BCC Publishing| Code - PHM211A

The global colorectal cancer therapeutics market should reach $18.5 billion by 2023 from $13.7 billion in 2018 at a compound annual growth rate (CAGR) of 6.1% for the period 2018 to 2023.

Drugs of Abuse Testing: Technologies and Global Markets

Published - Apr 2019 | Publisher - BCC Publishing| Code - PHM013H

The global market for drugs of abuse (DOA) testing should grow from $3.5 billion in 2018 to $4.6 billion by 2023 with a compound annual growth rate (CAGR) of 5.6% for the period of 2018-2023.

Laboratory Animal Models, 3D Cultures and Organoids

Published - Apr 2019 | Publisher - BCC Publishing| Code - PHM204A

The global market for laboratory animal models should grow from $5.9 billion in 2018 to $7.8 billion by 2023, increasing at a compound annual growth rate (CAGR) of 5.6% for the period of 2018-2023.

2018 Pharmaceuticals Research Review

Published - Mar 2019 | Publisher - BCC Publishing| Code - PHM099F

2018 Pharmaceuticals Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making.

Laboratory Automation Systems and Processes: Global Markets and T...

Published - Mar 2019 | Publisher - BCC Publishing| Code - PHM201A

The global market for laboratory automation systems and processes should grow from $21.1 billion in 2018 to reach $29.2 billion by 2023 at a compound annual growth rate (CAGR) of 6.8% for the period of 2018-2023.

In Vitro Toxicity Testing: Technologies and Global Markets

Published - Feb 2019 | Publisher - BCC Publishing| Code - PHM017F

The global market for in vitro toxicity testing should grow from $7.4 billion in 2018 to reach $10.4 billion by 2023 at a compound annual growth rate (CAGR) of 7.1% for the period of 2018-2023.

High-Throughput Screening: Technologies and Global Markets

Published - Feb 2019 | Publisher - BCC Publishing| Code - PHM205A

The global high-throughput screening (HTS) market should reach $21.1 billion by 2023 from $14.4 billion in 2018 at a compound annual growth rate (CAGR) of 7.9% for the period 2018-2023.

Blood Cancer Therapeutics: Global Markets to 2023

Published - Jan 2019 | Publisher - BCC Publishing| Code - PHM210A

The global market for blood cancer therapeutics should grow from $38.5 billion in 2018 to $64.8 billion by 2023 at a compound annual growth rate (CAGR) of 11.0% from 2018 to 2023.

Brain Tumor Therapeutics: Global Markets to 2023

Published - Jan 2019 | Publisher - BCC Publishing| Code - PHM208A

The global market for brain tumor therapeutics should grow from $1.1 billion in 2018 to reach $2.0 billion by 2023 at a compound annual growth rate (CAGR) of 12.9% for the period of 2018-2023.

Global Cancer Therapeutics Market: Emphasis on Recurrent and Meta...

Published - Jan 2019 | Publisher - BCC Publishing| Code - PHM177B

The global cancer therapeutics market should grow from $128.1 billion in 2018 to $182.0 billion by 2023 at a compound annual growth rate (CAGR) of 7.3% for the period of 2018-2023.

Global Market for Contract Research Organization (CRO) Services

Published - Dec 2018 | Publisher - BCC Publishing| Code - PHM186A

The global market for CRO's across the clinical trial process should grow from $45.5 billion in 2017 to reach $72.3 billion by 2022 at a compound annual growth rate (CAGR) of 9.7% for the period of 2017-2022.

Opioid Drugs: Global Markets to 2023

Published - Dec 2018 | Publisher - BCC Publishing| Code - PHM207A

The global market for opioid drugs should reach $29.8 billion by 2023 from $26.4 billion in 2018 at a compound annual growth rate (CAGR) of 2.5% for the period of 2018-2023.

Antibiotics: Global Markets to 2023

Published - Dec 2018 | Publisher - BCC Publishing| Code - PHM209A

The global antibiotics market should reach $55.8 billion by 2023 from $38.3 billion in 2018 at a compound annual growth rate (CAGR) of 7.8% for the period of 2018-2023.

Lung Cancer Therapeutics: Global Markets

Published - Dec 2018 | Publisher - BCC Publishing| Code - PHM206A

The global market for lung cancer therapeutics should grow from $17.9 billion in 2018 to $26.3 billion by 2023, increasing at a compound annual growth rate (CAGR) of 8.0% from 2018 to 2023.

« 1 2 3 4 5 »

5 Upcoming Reports in Pharmaceuticals

Generic Opportunities in Pharmaceuticals Market to look for in the year 2019

Target Date - Dec 2019| Publisher - BCC Publishing | Code - PHM223A| Price - $5,500

Get an overview of opportunities for generic or biosimilar drugs in pharmaceuticals market 2019. Coverage of generics and discussion on their characteristics.

Non-injectable Insulin

Target Date - Jan 2020| Publisher - BCC Publishing | Code - PHM224A| Price - $3,950
Report Includes
  • An overview of global market for edible insulin
  • Analyses of market trends, with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Coverage of recent R&D events and insights into government initiatives taken for the development of edible insulin
  • Information on ORMD-0801 drug; which is an oral insulin
  • Knowledge about, technological descriptions and issues, applications, market factors, and projection of growth trends
  • Detailed company profiles of the leading players in the industry

Global Markets and Technologies for Advanced Drug Delivery Systems

Target Date - Mar 2020| Publisher - BCC Publishing | Code - PHM006L| Price - $5,500

Get an analysis of the advanced drug delivery market by technology systems, applications, routes of administration, and drug delivery vehicles.

Bioinks

Target Date - Mar 2020| Publisher - BCC Publishing | Code - PHM221A| Price - $3,950

Discussion of issues related to bioink manufacturing, types and main properties, and current and emerging trends in bioink production.

Nanotechnology in Cancer Treatment

Target Date - Mar 2020| Publisher - BCC Publishing | Code - PHM222A| Price - $3,950

Detailed overview of the current and emerging applications of nanotechnology in cancer treatment. Analyses of global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024

 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM